Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special Emphasis Panel, NIMH Program for Toxicological Evaluation of Novel Ligands.
Date: July 12, 2002.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate contract proposals.
Place: Bethesda Mariott, 5151 Pooks Hill Road, Bethesda, MD 20814.
Contact Person: Peter J. Sheridan, Ph.D., Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6142, MS 9606, Bethesda, MD 20892-9606, 301-443-1513, firstname.lastname@example.org.
(Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS)Start Signature
Dated: June 14, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-15761 Filed 6-20-02; 8:45 am]
BILLING CODE 4140-01-M